India
· Delayed Price · Currency is INR Indoco Remedies Statistics
Total Valuation
Indoco Remedies has a market cap or net worth of INR 23.37 billion. The enterprise value is 33.10 billion.
| Market Cap | 23.37B |
| Enterprise Value | 33.10B |
Important Dates
The last earnings date was Friday, May 16, 2025.
| Earnings Date | May 16, 2025 |
| Ex-Dividend Date | Sep 19, 2024 |
Share Statistics
| Current Share Class | 92.25M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -5.53% |
| Shares Change (QoQ) | +12.79% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 36.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 57.73 |
| PS Ratio | 1.40 |
| PB Ratio | 2.29 |
| P/TBV Ratio | 2.82 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 24.62 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 33.34, with an EV/FCF ratio of -12.67.
| EV / Earnings | -44.88 |
| EV / Sales | 1.99 |
| EV / EBITDA | 33.34 |
| EV / EBIT | n/a |
| EV / FCF | -12.67 |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.98.
| Current Ratio | 1.24 |
| Quick Ratio | 0.48 |
| Debt / Equity | 0.98 |
| Debt / EBITDA | 10.01 |
| Debt / FCF | -3.80 |
| Interest Coverage | -0.22 |
Financial Efficiency
Return on equity (ROE) is -7.32% and return on invested capital (ROIC) is -0.48%.
| Return on Equity (ROE) | -7.32% |
| Return on Assets (ROA) | -0.40% |
| Return on Invested Capital (ROIC) | -0.48% |
| Return on Capital Employed (ROCE) | -0.90% |
| Revenue Per Employee | 2.77M |
| Profits Per Employee | -122,900 |
| Employee Count | 5,929 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 1.29 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.27% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -22.27% |
| 50-Day Moving Average | 240.90 |
| 200-Day Moving Average | 296.50 |
| Relative Strength Index (RSI) | 56.63 |
| Average Volume (20 Days) | 5,174 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Indoco Remedies had revenue of INR 16.65 billion and -737.40 million in losses. Loss per share was -8.46.
| Revenue | 16.65B |
| Gross Profit | 11.67B |
| Operating Income | -145.80M |
| Pretax Income | -743.70M |
| Net Income | -737.40M |
| EBITDA | 992.60M |
| EBIT | -145.80M |
| Loss Per Share | -8.46 |
Balance Sheet
The company has 170.70 million in cash and 9.94 billion in debt, giving a net cash position of -9.76 billion.
| Cash & Cash Equivalents | 170.70M |
| Total Debt | 9.94B |
| Net Cash | -9.76B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 10.18B |
| Book Value Per Share | 113.36 |
| Working Capital | 1.93B |
Cash Flow
In the last 12 months, operating cash flow was 949.30 million and capital expenditures -3.56 billion, giving a free cash flow of -2.61 billion.
| Operating Cash Flow | 949.30M |
| Capital Expenditures | -3.56B |
| Free Cash Flow | -2.61B |
| FCF Per Share | n/a |
Margins
Gross margin is 70.08%, with operating and profit margins of -0.88% and -4.43%.
| Gross Margin | 70.08% |
| Operating Margin | -0.88% |
| Pretax Margin | -4.47% |
| Profit Margin | -4.43% |
| EBITDA Margin | 5.96% |
| EBIT Margin | -0.88% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 0.57%.
| Dividend Per Share | 1.50 |
| Dividend Yield | 0.57% |
| Dividend Growth (YoY) | -33.33% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.53% |
| Shareholder Yield | 6.10% |
| Earnings Yield | -3.16% |
| FCF Yield | -11.18% |
Stock Splits
The last stock split was on May 17, 2012. It was a forward split with a ratio of 7.5.
| Last Split Date | May 17, 2012 |
| Split Type | Forward |
| Split Ratio | 7.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |